摘要
Amyotrophic lateral sclerosis（ALS）is a rapidly progressive disorder characterized by the degeneration and subsequent loss of upper and lower motor neurons,resulting in reduced muscle function and paralysis（Mathis et al.,2017）.Current therapies are limited to the oral administration of riluzole,which improves survival by only 3 months（Mathis et al.,2017）.Thus,
Amyotrophic lateral sclerosis（ALS）is a rapidly progressive disorder characterized by the degeneration and subsequent loss of upper and lower motor neurons,resulting in reduced muscle function and paralysis（Mathis et al.,2017）.Current therapies are limited to the oral administration of riluzole,which improves survival by only 3 months（Mathis et al.,2017）.Thus,
基金
supported by the MND Research Institute of Australia and the Stanford Family MND Research Grant
supported by the National Health and Medical Research Council of Australia
US Department of Defense Therapeutic Ideas Grant
